This guide breaks down every piece of available evidence on retatrutide and body composition, explains exactly how much lean mass you can expect to lose, and provides research-backed protocols for keeping as much muscle as possible while maximizing fat loss
Ozempic and Wegovy maker Novo Nordisk terminated its collaboration with Hims and Hers in July 2025, citing illegal compounding and deceptive marketing
The key is setting proper expectations and helping clients understand the insurance industry's long-term risk perspective
Why Retatrutide Is Not FDA-Approved Yet Retatrutide is not FDA-approved because it is still being evaluated through clinical development
Overall, S-Acetyl-L-glutathione is a valuable compound with diverse applications, showing promise in potential therapeutic utility for lymphoma patients and clinical management of liver diseases in canines, and supporting overall health and well-being
Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding Novo Nordisk's shares plunged more than 20% Tuesday, after the company cut the forecast for its flagship obesity drug